Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
4.380
+0.010 (0.23%)
At close: Dec 29, 2025, 4:00 PM EST
4.460
+0.080 (1.83%)
After-hours: Dec 29, 2025, 4:28 PM EST
Genelux Market Cap
Genelux has a market cap or net worth of $164.77 million as of December 29, 2025. Its market cap has increased by 86.53% in one year.
Market Cap
164.77M
Enterprise Value
145.48M
1-Year Change
86.53%
Ranking
Category
Stock Price
$4.38
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has increased from $141.69M to $164.77M, an increase of 16.29%. That is a compound annual growth rate of 5.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 164.77M | 104.71% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 969.81B |
| Johnson & Johnson | 502.46B |
| AbbVie | 408.57B |
| UnitedHealth Group | 297.98B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.43B |
| Novo Nordisk | 232.28B |